Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart

被引:66
作者
Almeida, AP [1 ]
Frábregas, BC [1 ]
Madureira, MM [1 ]
Santos, RJS [1 ]
Campagnole-Santos, MJ [1 ]
Santos, RAS [1 ]
机构
[1] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil
关键词
angiotensin-(1-7); bradykinin; coronary artery; rat heart; L-NAME; prostaglandins; bradykinin potentiation;
D O I
10.1590/S0100-879X2000000600012
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has been shown that angiotensin-(1-7) (Ang-(1-7)) infusion potentiates the bradykinin (BK)-induced hypotensive response in conscious rats, The present study was conducted to identify Ang-(1-7)-BK interactions in the isolated rat heart perfused according to the Langendorff technique, Hearts were excised and perfused through the aortic stump under a constant flow with Krebs-Ringer solution and the changes in perfusion pressure and heart contractile force were recorded. Bolus injections of BK (2.5, 5, 10 and 20 ng) produced a dose-dependent hypotensive effect. Ang-(1-7) added to the perfusion solution (2 ng/ml) did not change the perfusion pressure or the contractile force but doubled the hypotensive effect of the lower doses of BK. The BK-potentiating Ang-(1-7) activity was blocked by pretreatment with indomethacin (5 mg/kg, ip) or L-NAME (30 mg/kg, ip), The Ang-(1-7) antagonist A-779 (50 ng/ml in Krebs-Ringer) completely blocked the effect of Ang-(1-7) on BK-induced vasodilation. These data suggest that the potentiation of the BK-induced vasodilation by Ang(1-7) can be attributed to the release of nitric oxide and vasodilator prostaglandins through an Ang-(1-7) receptor-mediated mechanism.
引用
收藏
页码:709 / 713
页数:5
相关论文
共 19 条
[1]   NEPHRECTOMY, CONVERTING-ENZYME INHIBITION, AND ANGIOTENSIN PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1993, 22 (04) :513-522
[2]   Metabolism of angiotension-(1-7) by angiotensin-converting enzyme [J].
Chappell, MC ;
Pirro, NT ;
Sykes, A ;
Ferrario, CM .
HYPERTENSION, 1998, 31 (01) :362-367
[3]   N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme angiotensin-(1-7) and Keto-ACE [J].
Deddish, PA ;
Marcic, B ;
Jackman, HL ;
Wang, HZ ;
Skidgel, RA ;
Erdös, EG .
HYPERTENSION, 1998, 31 (04) :912-917
[4]  
Dzau V J, 1988, Am J Med, V84, P22, DOI 10.1016/0002-9343(88)90201-X
[5]   Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system [J].
Ferrario, CM ;
Iyer, SN .
REGULATORY PEPTIDES, 1998, 78 (1-3) :13-18
[6]   BRADYKININ-MEDIATED EFFECTS OF ACE INHIBITION [J].
GAVRAS, I ;
MADIAS, NE ;
PONCE, P ;
WEIGERT, A ;
MOREIRA, J ;
NEVES, P ;
PRATA, M ;
NEGRAO, P ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1992, 42 (04) :1020-1029
[7]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IMPROVES CARDIAC-FUNCTION - ROLE OF BRADYKININ [J].
GOHLKE, P ;
LINZ, W ;
SCHOLKENS, BA ;
KUWER, I ;
BARTENBACH, S ;
SCHNELL, A ;
UNGER, T .
HYPERTENSION, 1994, 23 (04) :411-418
[8]   ACE inhibitor potentiation of bradykinin-induced venoconstriction [J].
Hecker, M ;
Blaukat, A ;
Bara, AT ;
MullerEsterl, W ;
Busse, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (07) :1475-1481
[9]   Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide [J].
Li, P ;
Chappell, MC ;
Ferrario, CM ;
Brosnihan, KB .
HYPERTENSION, 1997, 29 (01) :394-400
[10]   The varicocele in pediatric age: 207 cases treated with microsurgical technique [J].
Lima, M ;
Domini, M ;
Libri, M .
EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 1997, 7 (01) :30-33